Desmoid tumor of unspecified site
ICD-10 D48.119 is a billable code used to indicate a diagnosis of desmoid tumor of unspecified site.
Desmoid tumors, also known as aggressive fibromatosis, are benign neoplasms that arise from the connective tissue and are characterized by their infiltrative growth pattern. These tumors can occur in various anatomical locations, including the abdominal wall, limbs, and trunk, but when coded as D48.119, the specific site is not identified. Although classified as benign, desmoid tumors can exhibit aggressive behavior, leading to local recurrence and significant morbidity. They are often associated with familial adenomatous polyposis (FAP) syndrome, but can also occur sporadically. Diagnosis typically involves imaging studies such as MRI or CT scans, and histological examination confirms the diagnosis. Treatment options may include surgical excision, observation, or pharmacological interventions such as nonsteroidal anti-inflammatory drugs (NSAIDs) or hormonal therapies. Due to their uncertain behavior, ongoing surveillance is crucial to monitor for potential progression or recurrence, making accurate coding essential for appropriate management and resource allocation.
Detailed pathology reports, imaging studies, and treatment plans.
Management of desmoid tumors post-surgery, monitoring for recurrence.
Ensure clear documentation of tumor behavior and treatment response.
Operative reports detailing excision and margins.
Surgical intervention for desmoid tumors in various locations.
Document the extent of resection and any complications.
Used when excising a desmoid tumor from the thoracic region.
Operative report detailing the excision and margins.
Ensure clear documentation of tumor characteristics and surgical approach.
A desmoid tumor is a benign but aggressive neoplasm that arises from connective tissue, characterized by infiltrative growth and potential for local recurrence.
Treatment options include surgical excision, observation, and pharmacological therapies such as NSAIDs or hormonal treatments, depending on the tumor's size and location.
